Skip to content

The study of DNA methylation markers combined with metabonomics in the early surveillance and diagnosis of HCC

The study of DNA methylation markers combined with metabonomics in the early surveillance and diagnosis of HCC

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039860
Enrollment
Unknown
Registered
2020-11-12
Start date
2021-06-01
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis B associated liver cancer

Interventions

Gold Standard:For the diagnosis of chronic hepatitis B and hepatitis B cirrhosis, refer to the guidelines for prevention and treatment of chronic hepatitis B (2015 updated edition) issued by the Chine
for hepatitis B related liver cancer and clinical stages, refer to EASL guidelines for managemen
diagnosis&#32
model&#32
of&#32
CGS&#32
and&#32

Sponsors

Beijing You'an Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Sign informed consent form; 2. Aged 18-70 years; 3. Gender: unlimited; 4. Nationality or region: unlimited; 5. The diagnosis was in accordance with the diagnostic criteria. Diagnostic criteria: chronic hepatitis B and hepatitis B cirrhosis were diagnosed according to the guidelines for the prevention and treatment of chronic hepatitis B (2015 updated edition) issued by the Chinese Medical Association; EASL clinical practice guidelines: management of hepatocellular carcinoma (Journal of Hepatology, 2018 Vol. 69. 182 – 236); early liver cancer: stage 0 (very) Early stage and early stage.

Exclusion criteria

Exclusion criteria: 1. Non hepatitis B related liver disease or liver cancer; 2. Pregnant women or perinatal women; 3. Patients with a history of malignant tumor other than primary liver cancer.

Design outcomes

Primary

MeasureTime frame
SEN, SPE, ACC, AUC of ROC, PPV, NPV;

Countries

China

Contacts

Public ContactYonghong Zhang
13810108505@163.com+86 10-83997462

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026